Matches in Nanopublications for { ?s ?p "[A single-nucleotide polymorphism at -670 of Fas gene promoter (A/G) was examined in a total of 400 blood samples from normal healthy women and cervical cancer patients, using polymerase chain reaction and restriction fragment length polymorphism (PCR-RFLP) technique.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 11 of
11
with 100 items per page.
- assertion description "[A single-nucleotide polymorphism at -670 of Fas gene promoter (A/G) was examined in a total of 400 blood samples from normal healthy women and cervical cancer patients, using polymerase chain reaction and restriction fragment length polymorphism (PCR-RFLP) technique.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP52554.RAYHCJ2nj8aXbyNSAkcPjkmBMZ3PicGRTM4AJ8vboFzxY130_assertion description "[A single-nucleotide polymorphism at -670 of Fas gene promoter (A/G) was examined in a total of 400 blood samples from normal healthy women and cervical cancer patients, using polymerase chain reaction and restriction fragment length polymorphism (PCR-RFLP) technique.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP52554.RAYHCJ2nj8aXbyNSAkcPjkmBMZ3PicGRTM4AJ8vboFzxY130_provenance.
- NP248192.RAQR0pw5WdO1uLO8rCr5jzlPBENRCazHJhNvEQMg8WueQ130_assertion description "[A single-nucleotide polymorphism at -670 of Fas gene promoter (A/G) was examined in a total of 400 blood samples from normal healthy women and cervical cancer patients, using polymerase chain reaction and restriction fragment length polymorphism (PCR-RFLP) technique.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP248192.RAQR0pw5WdO1uLO8rCr5jzlPBENRCazHJhNvEQMg8WueQ130_provenance.
- NP394987.RAetrGHZ57g2xIfBZdJzXbEVDJY9DyIOKNrNQD9QUpiJo130_assertion description "[A single-nucleotide polymorphism at -670 of Fas gene promoter (A/G) was examined in a total of 400 blood samples from normal healthy women and cervical cancer patients, using polymerase chain reaction and restriction fragment length polymorphism (PCR-RFLP) technique.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP394987.RAetrGHZ57g2xIfBZdJzXbEVDJY9DyIOKNrNQD9QUpiJo130_provenance.
- NP690235.RASKdxw-JCH8kuO9OAojaX2BlxdY2AqTr0NjIHELPwabc130_assertion description "[A single-nucleotide polymorphism at -670 of Fas gene promoter (A/G) was examined in a total of 400 blood samples from normal healthy women and cervical cancer patients, using polymerase chain reaction and restriction fragment length polymorphism (PCR-RFLP) technique.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP690235.RASKdxw-JCH8kuO9OAojaX2BlxdY2AqTr0NjIHELPwabc130_provenance.
- NP690232.RAiOTZAdXitCRn2us21q0qAOcKUXwCdobxc4SYN45OANw130_assertion description "[A single-nucleotide polymorphism at -670 of Fas gene promoter (A/G) was examined in a total of 400 blood samples from normal healthy women and cervical cancer patients, using polymerase chain reaction and restriction fragment length polymorphism (PCR-RFLP) technique.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP690232.RAiOTZAdXitCRn2us21q0qAOcKUXwCdobxc4SYN45OANw130_provenance.
- NP690233.RAknBdUjkU8mTSykRKcCx8j76OxbPybgdN-4odeK4A3CI130_assertion description "[A single-nucleotide polymorphism at -670 of Fas gene promoter (A/G) was examined in a total of 400 blood samples from normal healthy women and cervical cancer patients, using polymerase chain reaction and restriction fragment length polymorphism (PCR-RFLP) technique.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP690233.RAknBdUjkU8mTSykRKcCx8j76OxbPybgdN-4odeK4A3CI130_provenance.
- NP690234.RAlrF6VGGCz6Y953EkM3T1KjYYmuZ7rT-YEcuhj_VGiF0130_assertion description "[A single-nucleotide polymorphism at -670 of Fas gene promoter (A/G) was examined in a total of 400 blood samples from normal healthy women and cervical cancer patients, using polymerase chain reaction and restriction fragment length polymorphism (PCR-RFLP) technique.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP690234.RAlrF6VGGCz6Y953EkM3T1KjYYmuZ7rT-YEcuhj_VGiF0130_provenance.
- NP248616.RA3016_zSqOG8YhE0DlEErVLTro9s1cJEdfenIKT6g5SY130_assertion description "[A single-nucleotide polymorphism at -670 of Fas gene promoter (A/G) was examined in a total of 400 blood samples from normal healthy women and cervical cancer patients, using polymerase chain reaction and restriction fragment length polymorphism (PCR-RFLP) technique.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP248616.RA3016_zSqOG8YhE0DlEErVLTro9s1cJEdfenIKT6g5SY130_provenance.
- NP395332.RAGL_U99s7nXabVJfb8r_Wl2RBIePzkLfDQWc15NQPF-I130_assertion description "[A single-nucleotide polymorphism at -670 of Fas gene promoter (A/G) was examined in a total of 400 blood samples from normal healthy women and cervical cancer patients, using polymerase chain reaction and restriction fragment length polymorphism (PCR-RFLP) technique.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP395332.RAGL_U99s7nXabVJfb8r_Wl2RBIePzkLfDQWc15NQPF-I130_provenance.
- NP129185.RA6XM3QC_kl-XDvlBHdG-j5HmHNzhPFOLfvDmGDNWRoX4130_assertion description "[A single-nucleotide polymorphism at -670 of Fas gene promoter (A/G) was examined in a total of 400 blood samples from normal healthy women and cervical cancer patients, using polymerase chain reaction and restriction fragment length polymorphism (PCR-RFLP) technique.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP129185.RA6XM3QC_kl-XDvlBHdG-j5HmHNzhPFOLfvDmGDNWRoX4130_provenance.